| |
| |
|
| Insider
Information: |
Elam Nevan C |
| Relationship: |
Director |
| City: |
San Carlos |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
31,717 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$133,935 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
31,717 |
|
|
| Total
Value |
$133,935 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
1
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
-1.0
|
| Percentage
Gain/Loss : |
 81.1%
|
 -2.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Nektar Therapeutics |
NKTR |
SVP, Head Pulmonary Bu... |
2007-05-14 |
1,400 |
2007-05-14 |
0 |
Premium* |
|
|
Rezolute, Inc |
RZLT |
|
2024-02-26 |
7,817 |
2015-02-09 |
0 |
Premium* |
|
|
Savara Inc |
SVRA |
Director |
2023-12-28 |
22,500 |
2019-02-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RZLT |
Rezolute, Inc |
CEO |
• • – |
2024-02-26 |
4 |
B |
$1.68 |
$8,400 |
D/D |
5,000 |
7,817 |
0.01 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2023-12-28 |
4 |
S |
$4.71 |
$442,291 |
D/D |
(93,843) |
22,500 |
0 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2023-12-28 |
4 |
OE |
$0.82 |
$69,722 |
D/D |
53,758 |
116,343 |
0 |
- |
|
| SVRA |
Savara Inc |
Director |
– • – |
2023-12-14 |
4 |
A |
$0.00 |
$0 |
D/D |
22,500 |
62,585 |
0 |
- |
|
| SVRA |
Savara Inc |
Director |
– • – |
2023-12-11 |
4 |
OE |
$0.82 |
$8,890 |
D/D |
10,841 |
40,085 |
0 |
- |
|
| SVRA |
Savara Inc |
Director |
– • – |
2022-12-13 |
4 |
OE |
$0.65 |
$762 |
D/D |
1,172 |
29,244 |
0 |
- |
|
| SVRA |
Savara Inc |
Director |
– • – |
2021-12-06 |
4 |
OE |
$0.55 |
$645 |
D/D |
1,172 |
28,072 |
0 |
- |
|
| SVRA |
Savara Inc |
Director |
– • – |
2021-08-18 |
4 |
OE |
$0.52 |
$1,190 |
D/D |
2,288 |
26,900 |
0 |
- |
|
| SVRA |
Savara Inc |
Director |
– • – |
2020-12-15 |
4 |
OE |
$0.52 |
$1,524 |
D/D |
2,930 |
24,612 |
0 |
- |
|
| SVRA |
Savara Inc |
Director |
– • – |
2019-02-04 |
4 |
OE |
$0.19 |
$4,120 |
D/D |
21,682 |
21,682 |
0 |
- |
|
| RZLT |
Rezolute, Inc |
Chief Executive Officer |
• • – |
2015-02-09 |
4 |
S |
$0.00 |
$0 |
I/I |
(842,949) |
0 |
0 |
- |
|
| RZLT |
Rezolute, Inc |
Chief Executive Officer |
• • • |
2014-03-31 |
4 |
A |
$275,000.00 |
$2,147,483,647 |
I/I |
1,057,693 |
5,057,693 |
0 |
- |
|
| RZLT |
Rezolute, Inc |
Chief Executive OfficerOfficer |
• • • |
2013-01-31 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,000,000 |
|
- |
|
| NKTR |
Nektar Therapeutics |
SVP, Head Pulmonary Bus. Unit |
• – – |
2007-05-14 |
4 |
A |
$0.01 |
$14 |
D/D |
1,400 |
1,400 |
0 |
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
